Skip to Content

Mecasermin Injection

Last Updated: January 14, 2016
Status: Resolved

Products Affected - Description

Increlex Injection, Ipsen Pharmaceuticals 

Reason for the Shortage

  • Ipsen Pharmaceuticals states the shortage was due to a manufacturing delay and raw material shortage.
  • Ipsen was working with FDA to allow the release of Increlex lot #441453F. This lot was produced at an alternate manufacturing site that has not been approved by FDA. Please see the Dear Health Care Professional letter for additional information.

Available Products

Increlex Injection, Ipsen Pharmaceuticals
10 mg/mL 4 mL vials, package of 10 (NDC 15054-1040-05)

Estimated Resupply Dates

Ipsen has Increlex injection available. In order to obtain Increlex, all patients need to go through Ipsen’s patient service and support program, Ipsen Cares.

Related Shortages


January 14, 2016; October 20, 2014; September 22, 2014; August 13, 2014; July 7, 2014; June 3, 2014; May 19, 2014; May 7, 2014; March 3, 2014; January 6, 2014; October 28, 2013; September 18, 2013, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.